EPRUMA members call the EU Parliamentarians for their support to adopt the draft Commission delegated regulation (DEA 2021/2718) on “Criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans”.
EPRUMA call for support is based on the following 5 arguments:
- Science based decision making
The European Medicines Agency scientific advice takes into account both the WHO and the OIE, but importantly also has adapted advice to the European health and resistance situation. The Delegated act is based on EMA’s scientific advice and should not be challenged.
Banning authorised antimicrobials for animals without any scientific argument and science-based reasons is counter-productive and increases potential risks.
- Responsible use
It needs to be reiterated that the ultimate target is the reduction of levels of antimicrobial resistance.
- Animal health and welfare
Imposing additional restrictions without robust scientific arguments and going beyond the defined criteria in the delegated act, will cause significant animal health and welfare problems as certain bacterial infections would no longer be able to be treated.
- One Health
Antimicrobial resistance is threatening public health and our society. To combat it, a ‘One Health’ approach is needed as human health, animal health and the environment are all interlinked. Actions in one sector alone cannot solve this problem, as recognized also by the ‘EC One Health AMR Action Plan’.